GLP-1 treatment linked to lower risk of hospitalization and death in older adults with fatty liver disease
A new Houston Methodist Research Institute study finds that older adults with metabolic dysfunction-associated steatotic liver disease (MASLD) who received GLP-1-based treatment experienced significantly lower risks of liver disease–related complications, hospitalization and death compared with similar patients who did not receive the treatment.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Alcohol and the brain interact through immune cells, new research shows
-
Robotic surgery enables effective and safe repair of hard-to-reach abdominal hernias
-
<i><em>WH</em></i> Approved: A Fitness Editor’s Honest Review of the New On Train Tights with FormTec™
-
Building a Fall Wardrobe? Start With These Affordable Uniqlo Staples
-
2,000-year-old burial found in Russia near a human sacrifice and a cup to ward off magical threats
-
Yo-yo dieting may pose different risks depending on starting weight
-
'I won't trust AI': Readers share mixed reaction to AI tools that calculate people's biological ages
-
Had genetic testing for cancer risk years ago? Newer tests may find what old ones missed